129 related articles for article (PubMed ID: 34966292)
1. Relationship Between Fatty Acid Binding Protein 4 and Liver Fat in Individuals at Increased Cardiometabolic Risk.
Rodríguez-Calvo R; Moreno-Vedia J; Girona J; Ibarretxe D; Martínez-Micaelo N; Merino J; Plana N; Masana L
Front Physiol; 2021; 12():781789. PubMed ID: 34966292
[No Abstract] [Full Text] [Related]
2. Circulating level of fatty acid-binding protein 4 is an independent predictor of metabolic dysfunction-associated fatty liver disease in middle-aged and elderly individuals.
Tanaka M; Takahashi S; Higashiura Y; Sakai A; Koyama M; Saitoh S; Shimamoto K; Ohnishi H; Furuhashi M
J Diabetes Investig; 2022 May; 13(5):878-888. PubMed ID: 34889064
[TBL] [Abstract][Full Text] [Related]
3. Role of fatty liver index in risk-stratifying comorbid disease outcomes in non-alcoholic fatty liver disease.
Ho B; Thompson A; Jorgensen AL; Pirmohamed M
JHEP Rep; 2023 Dec; 5(12):100896. PubMed ID: 37928746
[TBL] [Abstract][Full Text] [Related]
4. Associations between serum clusterin levels and non-alcoholic fatty liver disease.
Wang Y; Shen Y; Hu T; Wang Y; Ma X; Yu H; Bao Y
Endocr Connect; 2023 Jul; 12(7):. PubMed ID: 37043769
[TBL] [Abstract][Full Text] [Related]
5. Incidence of non-alcoholic fatty liver disease and metabolic dysfunction in first episode schizophrenia and related psychotic disorders: a 3-year prospective randomized interventional study.
Morlán-Coarasa MJ; Arias-Loste MT; Ortiz-García de la Foz V; Martínez-García O; Alonso-Martín C; Crespo J; Romero-Gómez M; Fábrega E; Crespo-Facorro B
Psychopharmacology (Berl); 2016 Dec; 233(23-24):3947-3952. PubMed ID: 27620899
[TBL] [Abstract][Full Text] [Related]
6. Fatty Liver Index (FLI) Identifies Not Only Individuals with Liver Steatosis but Also at High Cardiometabolic Risk.
Carli F; Sabatini S; Gaggini M; Sironi AM; Bedogni G; Gastaldelli A
Int J Mol Sci; 2023 Sep; 24(19):. PubMed ID: 37834099
[TBL] [Abstract][Full Text] [Related]
7. Calorie-Restricted Mediterranean and Low-Fat Diets Affect Fatty Acid Status in Individuals with Nonalcoholic Fatty Liver Disease.
Ristic-Medic D; Kovacic M; Takic M; Arsic A; Petrovic S; Paunovic M; Jovicic M; Vucic V
Nutrients; 2020 Dec; 13(1):. PubMed ID: 33374554
[TBL] [Abstract][Full Text] [Related]
8. Advanced glycation end product: A potential biomarker for risk stratification of non-alcoholic fatty liver disease in ELSA-Brasil study.
Pereira ENGDS; Paula DP; de Araujo BP; da Fonseca MJM; Diniz MFHS; Daliry A; Griep RH
World J Gastroenterol; 2021 Aug; 27(29):4913-4928. PubMed ID: 34447235
[TBL] [Abstract][Full Text] [Related]
9. Noninvasive biomarkers of non-alcoholic fatty liver disease in patients with metabolic syndrome: insights from the RESOLVE Study.
Ennequin G; Buchard B; Pereira B; Bonjean L; Courteix D; Lesourd B; Chapier R; Obert P; Vinet A; Walther G; Zak M; Bagheri R; Ugbolue CU; Abergel A; Dutheil F; Thivel D
Minerva Gastroenterol (Torino); 2023 Dec; 69(4):494-503. PubMed ID: 35144365
[TBL] [Abstract][Full Text] [Related]
10. Comparison of fatty liver index with noninvasive methods for steatosis detection and quantification.
Zelber-Sagi S; Webb M; Assy N; Blendis L; Yeshua H; Leshno M; Ratziu V; Halpern Z; Oren R; Santo E
World J Gastroenterol; 2013 Jan; 19(1):57-64. PubMed ID: 23326163
[TBL] [Abstract][Full Text] [Related]
11. Fatty liver index and hepatic steatosis index for prediction of non-alcoholic fatty liver disease in type 1 diabetes.
Sviklāne L; Olmane E; Dzērve Z; Kupčs K; Pīrāgs V; Sokolovska J
J Gastroenterol Hepatol; 2018 Jan; 33(1):270-276. PubMed ID: 28464337
[TBL] [Abstract][Full Text] [Related]
12. Fatty liver index (FLI) and prediction of new cases of non-alcoholic fatty liver disease: A population-based study of northern Iran.
Motamed N; Faraji AH; Khonsari MR; Maadi M; Tameshkel FS; Keyvani H; Ajdarkosh H; Karbalaie Niya MH; Rezaie N; Zamani F
Clin Nutr; 2020 Feb; 39(2):468-474. PubMed ID: 30922791
[TBL] [Abstract][Full Text] [Related]
13. Prevalence and predictors of non-alcoholic fatty liver disease as defined by the fatty liver index in a type 2 diabetes population.
Silaghi CA; Silaghi H; Colosi HA; Craciun AE; Farcas A; Cosma DT; Hancu N; Pais R; Georgescu CE
Clujul Med; 2016; 89(1):82-8. PubMed ID: 27004029
[TBL] [Abstract][Full Text] [Related]
14. Ultrasonographic fatty liver indicator detects mild steatosis and correlates with metabolic/histological parameters in various liver diseases.
Ballestri S; Nascimbeni F; Baldelli E; Marrazzo A; Romagnoli D; Targher G; Lonardo A
Metabolism; 2017 Jul; 72():57-65. PubMed ID: 28641784
[TBL] [Abstract][Full Text] [Related]
15. Relationship between non-alcoholic fatty liver disease and benign prostatic hyperplasia/lower urinary tract symptoms: new insights from an Italian cross-sectional study.
Russo GI; Cimino S; Fragalà E; Privitera S; La Vignera S; Condorelli R; Calogero AE; Chisari M; Castelli T; Favilla V; Morgia G
World J Urol; 2015 May; 33(5):743-51. PubMed ID: 25189458
[TBL] [Abstract][Full Text] [Related]
16. Comparison of fatty liver index with fibroscan in non-alcoholic fatty liver disease.
Ahmed M; Saeed R; Kamani L; Durrani N; Ahmed F
J Family Med Prim Care; 2024 Apr; 13(4):1488-1495. PubMed ID: 38827715
[TBL] [Abstract][Full Text] [Related]
17. Comparison of four non-alcoholic fatty liver disease detection scores in a Caucasian population.
Lind L; Johansson L; Ahlström H; Eriksson JW; Larsson A; Risérus U; Kullberg J; Oscarsson J
World J Hepatol; 2020 Apr; 12(4):149-159. PubMed ID: 32685107
[TBL] [Abstract][Full Text] [Related]
18. Validation of fatty liver index and hepatic steatosis index for screening of non-alcoholic fatty liver disease in adults with obstructive sleep apnea hypopnea syndrome.
Chen LD; Huang JF; Chen QS; Lin GF; Zeng HX; Lin XF; Lin XJ; Lin L; Lin QC
Chin Med J (Engl); 2019 Nov; 132(22):2670-2676. PubMed ID: 31765354
[TBL] [Abstract][Full Text] [Related]
19. Leptin, free leptin index, insulin resistance and liver fibrosis in children with non-alcoholic fatty liver disease.
Nobili V; Manco M; Ciampalini P; Diciommo V; Devito R; Piemonte F; Comparcola D; Guidi R; Marcellini M
Eur J Endocrinol; 2006 Nov; 155(5):735-43. PubMed ID: 17062890
[TBL] [Abstract][Full Text] [Related]
20. Association between non alcoholic fatty liver disease, metabolic and vascular risk.
Elosua-Bayés I; Beloqui Ruiz Ó
Clin Investig Arterioscler; 2020; 32(5):200-205. PubMed ID: 32736892
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
